IfLS News Archive

April 2012

Scientists from the University of Southampton and Synairgen, a respiratory drug development company spun out from the University, can announce positive data from its Phase II clinical trial, into the effectiveness of the drug SNG001 (inhaled interferon beta) for asthma patients.

Scientists at the Medical Research Council (MRC) Lifecourse Epidemiology Unit at the University of Southampton have participated in the largest international study of its kind to identify the genes responsible for osteoporosis.